Icon

ROCALTROL (nda018044)- (0.25MCG,0.5MCG)

CALCITRIOL ESJAY PHARMA
0.25MCG,0.5MCG
No No
2000-Jul-05 Expired
None None
None No
*Predialysis Patients: Rocaltrol is indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15 to 55 mL/min) not yet on dialysis. *Dialysis Patients: Rocaltrol is indicated in the management of hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis. *Hypoparathyroidism Patients: Rocaltrol is also indicated in the management of hypocalcemia and its clinical manifestations in patients with postsurgical hypoparathyroidism, idiopathic hypoparathyroidism, and pseudohypoparathyroidism.
6 0 6
Total Other Developers None
Drugs with Suitability No
0.25MCG ** ** - 5 -
0.5MCG ** ** - - 4
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** **** ******** ******* ******** **** *********** ************* ******* *, ********, ***** *****, ******* (***) ***
****** ***** ******** ****** *********, *** *********** **** ******* ***** *****, ** **********, ******* (**) *****-****, ****** ****** (***) ***
****** ********** ******* ******** ***. *********** **** ******* **, **** *****, ***** ******** (**) *****, ****** ****** (***) ***
****** ******* ****** ******* ****** ******* ******* *********** ** **/*,******************, ********* *****, ****** *****, *********, ********* ******, ***** (***) ***
****** ****** ****** ****** *************** ** *** ****, *** *********** ** ********** **, **********, *** **** (**) *****-****, ****** ****** (***) ***
****** *** ***** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.